Pulished Date October, 2018
ID: 65
Share on
Share on

Latin America Veterinary Vaccines Market By Type (Livestock Vaccines And Companion Vaccines), By Technology (live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines And Conjugate Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: October, 2018
ID: 65
Pages: 132

The Latin America animal vaccines market is poised to reach USD 0.85 Billion by 2023 from USD 0.63 Billion in 2018, at a CAGR of 6.2%. The veterinary vaccines market has seen significant growth over the past few years, due to fear of imminent epidemics that have led to substantial losses particularly in poultry segment. Especially in Latin America, where the zoonotic epidemics are prevalent the market has been witnessing a substantial boost.

Veterinary vaccine market has received a significant boost in the past decade which can be accredited to increasing husbandry practices and better management of farms. Agriculture is a major practice in Latin America accounting for 11% of world food production. The cattle and other animals related with this are duly vaccinated which is the prime reason for market growth in this region. Also the Latin America veterinary vaccines market has shown considerable progress during the past few years with the growing pet healthcare conditions. Now, majority of countries provide insurance for pet vaccinations which resulted in a growth in canine and feline vaccinations segment.

Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans are common in this region since majority if this lies in the tropical region of Amazon basin. Increasing investments by leading players, like Merck Animal Health acquiring Vallée which is prominent in Brazil, Paraguay, Venezuela opens doors for their products into untapped regions. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market.

The Latin America veterinary vaccines market has been categorized as livestock animals and companion animals’ vaccines. The livestock vaccines segment has been further segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. Similarly, the canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. Furthermore, based on geography the Latin America market is analysed under various regions namely, Brazil, Argentina and Mexico.

Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                           

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                      

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1 By Type                                                                        

                                5.1.1 Livestock vaccines                                                






                                5.1.2 Companion vaccines                                                           



                5.2 Technology                                                                 

                                5.2.1 Live attenuated vaccines                                                  

                                5.2.2 Inactivated vaccines                                                            

                                5.2.3 Recombinant vaccines                                                       

                                5.2.4 Toxoid vaccines                                                     

                                5.2.5 Subunit vaccines                                                   

                                5.2.6 DNA vaccines                                                         

                                5.2.7 Conjugate vaccines                                                             

  1. Geographical Analysis

                6.1 Introduction                                                                               

                6.2 Brazil                                                                             

                6.3 Argentina                                                                    

                6.4 Mexico                                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Bayer Healthcare AG                                                                              

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Bioniche Animal Health Canada                                                                         

                8.3 Sanofi Animal Health Inc.                                                                      

                8.4 Biogenesis Bago SA                                                                 

                8.5 Heska Corporation                                                                  

                8.6 Indian Immunologicals Ltd.                                                                  

                8.7 Boehringer Ingelheim GmbH                                                                              

                8.8 Novartis Animal Health, Inc.                                                                

                8.9 Merck & Co. Inc.                                                                       

                8.10 Protein Sciences                                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Veterinary Vaccines Market By Region, From 2018-2023 ( USD Billion )
  2. Latin America Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
  3. Latin America Livestock vaccines Market By Region, From 2018-2023 ( USD Billion )
  4. Latin America Companion vaccines Market By Region, From 2018-2023 ( USD Billion )
  5. Latin America Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
  6. Latin America Live attenuated vaccines Market By Region, From 2018-2023 ( USD Billion )
  7. Latin America Inactivated vaccines Market By Region, From 2018-2023 ( USD Billion )
  8. Latin America Recombinant vaccines Market By Region, From 2018-2023 ( USD Billion )
  9. Latin America Toxoid vaccines Market By Region, From 2018-2023 ( USD Billion )
  10. Latin America Subunit vaccines Market By Region, From 2018-2023 ( USD Billion )
  11. Latin America DNA vaccines Market By Region, From 2018-2023 ( USD Billion )
  12. Latin America Conjugate vaccines Market By Region, From 2018-2023 ( USD Billion )
  13. Latin America Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
  14. Latin America Bovine Market By Region, From 2018-2023 ( USD Billion )
  15. Latin America porcine Market By Region, From 2018-2023 ( USD Billion )
  16. Latin America Ovine Market By Region, From 2018-2023 ( USD Billion )
  17. Latin America Poultry Market By Region, From 2018-2023 ( USD Billion )
  18. Latin America Equine Market By Region, From 2018-2023 ( USD Billion )
  19. Latin America Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
  20. Latin America canine Market By Region, From 2018-2023 ( USD Billion )
  21. Latin America feline Market By Region, From 2018-2023 ( USD Billion )
  22. Brazil Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
  23. Brazil Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
  24. Argentina Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
  25. Argentina Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
  26. Mexico Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
  27. Mexico Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
  28. Brazil Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
  29. Argentina Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
  30. Mexico Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
  31. Brazil Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
  32. Argentina Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
  33. Mexico Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )


$ 1234 2875